NeuBase Therapeutics lowers stockholder meeting quorum to one-third of shares

NeuBase Therapeutics, Inc.

Board approved bylaw amendment effective September 15, 2023.
Quorum changed to one-third of shares outstanding and entitled to vote.
Amendment intended to improve ability to hold stockholder meetings.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

NeuBase Therapeutics, Inc.: Changed quorum requirement for stockholder meetings to one-third of outstanding shares entitled to vote (effective 2023-09-15).

Change: bylaw amendment
Effective: 2023-09-15

Exact text from the filing

On September 15, 2023, the Board of Directors of NeuBase Therapeutics, Inc. (the “Company”) approved an amendment of the Company’s Amended and Restated Bylaws (the “Bylaws”), effective as of September 15, 2023, to change the quorum for the transaction of business at stockholder meetings to one-third of the shares of stock outstanding and entitled to vote at the meeting.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001104659-23-101595

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.